Why S&P 500 Pain Could Turn to Gain
The S&P 500 has had a tough start to the year, a notable shift from 2023’s robust gains. Several strategists, however, see a rally coming later in the year.
Source: marketwatch.com
Stay updated with breaking news from Street Notes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The S&P 500 has had a tough start to the year, a notable shift from 2023’s robust gains. Several strategists, however, see a rally coming later in the year.
Fewer analysts are upbeat about shares of the maker of the iPhone than at this time last year.
With biotech stocks off their highs, potential acquisitions include Immunocore, Syndax, and Blueprint, according to analysts.
Stifel raised its forecast for 2024 growth in digital ad revenue to 8% from 7.2%.
The profit reports come as the tide appears to be turning for bank stocks after a tough year.